Literature DB >> 10397936

Proliferation of endothelial cells on surface-immobilized albumin-heparin conjugate loaded with basic fibroblast growth factor.

G W Bos1, N M Scharenborg, A A Poot, G H Engbers, T Beugeling, W G van Aken, J Feijen.   

Abstract

Seeding of endothelial cells (ECs) on the luminal surface of small-diameter vascular grafts is a promising method to avoid occlusion of these prostheses. Immobilization of basic fibroblast growth factor (bFGF) to substrates used to coat or fill porous prostheses may enhance the formation of a confluent monolayer of ECs. Human umbilical vein endothelial cells (HUVECs) were grown on bFGF-loaded albumin-heparin conjugate bound to CO2 gas-plasma-treated polystyrene. In the order of 2-3 ng/cm2 bFGF had to be immobilized to form a confluent monolayer of HUVECs. The most prominent effect of surface-immobilized bFGF was stimulation of the proliferation shortly after seeding, resulting within 3 days in confluent cell monolayers with high density. In contrast, in cultures with 0.3 ng/mL bFGF in the medium instead of bFGF bound to the surface, it took almost a week before the cell layers reached confluency. Binding of bFGF to heparin and the biological activity of bFGF towards ECs were not influenced by the (radio-)labeling of bFGF with iodine. However, only a minor part of the bFGF used in this study displayed heparin affinity. Furthermore, degradation and multimerization of labeled bFGF in time occurred when the growth factor was stored at 20 degrees -37 degrees C. This limits the use of labeled bFGF to short-term (hours) experiments. In conclusion, bFGF loading of vascular graft surfaces through complexation of bFGF with a heparin-containing matrix probably will lead to more rapid formation of a confluent monolayer of ECs on graft surfaces upon seeding of the cells. Copyright 1999 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397936     DOI: 10.1002/(sici)1097-4636(19990305)44:3<330::aid-jbm12>3.0.co;2-o

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  7 in total

1.  Thromboresistant and endothelialization effects of dopamine-mediated heparin coating on a stent material surface.

Authors:  In-Ho Bae; In-Kyu Park; Dae Sung Park; Haeshin Lee; Myung Ho Jeong
Journal:  J Mater Sci Mater Med       Date:  2012-03-03       Impact factor: 3.896

Review 2.  Emerging microtechnologies for the development of oral drug delivery devices.

Authors:  Hariharasudhan D Chirra; Tejal A Desai
Journal:  Adv Drug Deliv Rev       Date:  2012-09-06       Impact factor: 15.470

3.  Analytical approaches to uptake and release of hydrogel-associated FGF-2.

Authors:  A Zieris; S Prokoph; P B Welzel; M Grimmer; K R Levental; W Panyanuwat; U Freudenberg; C Werner
Journal:  J Mater Sci Mater Med       Date:  2009-10-23       Impact factor: 3.896

4.  Sterilization effects on starPEG coated polymer surfaces: characterization and cell viability.

Authors:  Júlia Lleixà Calvet; Dirk Grafahrend; Doris Klee; Martin Möller
Journal:  J Mater Sci Mater Med       Date:  2008-01-29       Impact factor: 3.896

Review 5.  Micro/nanofabricated platforms for oral drug delivery.

Authors:  Cade B Fox; Jean Kim; Long V Le; Cameron L Nemeth; Hariharasudhan D Chirra; Tejal A Desai
Journal:  J Control Release       Date:  2015-08-02       Impact factor: 9.776

6.  Cellular Responses Modulated by FGF-2 Adsorbed on Albumin/Heparin Layer-by-Layer Assemblies.

Authors:  Marta Kumorek; Dana Kubies; Elena Filová; Milan Houska; Naresh Kasoju; Eliška Mázl Chánová; Roman Matějka; Markéta Krýslová; Lucie Bačáková; František Rypáček
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

7.  The choice of biopolymer is crucial to trigger angiogenesis with vascular endothelial growth factor releasing coatings.

Authors:  Christiane Claaßen; Miriam Dannecker; Jana Grübel; Maria-Elli Kotzampasi; Günter E M Tovar; Boris V Stanzel; Kirsten Borchers
Journal:  J Mater Sci Mater Med       Date:  2020-10-27       Impact factor: 3.896

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.